chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had my vaccination on 03/17/2022. I started to feel unwell on 06/07/2022 with low energy coughing lethargic fatigue. On 06/09/2023 I tested COVID-19 positive at home. I contacted my physician on 06/09/2022 but I had fallen out of the timeline of prescription. I was provided advice for over-the-counter treatment. I did not work for 3 weeks as I was still COVID-19 positive.
Chills, Migraine, Shakes, Weakness, shallow breathing palpitations, chest pain that spread to my whole back
About one hour after vaccine she developed itch of the face. She came back to be seen about two hours later (three hours after vaccine) because symptoms were stable and not resolving. No cough, dyspnea, rash, GI SX, dysphagia, etc.  Seen in clinic and looked well. No rash or redness. Given Benadryl 50mg PO which she has used in the past for similar symptoms. All symptoms were resolved about one hour after PO Benadryl  (four hours after vaccine). Never had any abnormal signs.
Chills, headache, fatigue, temporary cognitive dysfunction (I couldn't remember how to do my job for about half an hour) The other effects lasted about 48 hours
CHILD'S DATE OF BIRTH WRITTEN AS 1/13/2009 AND AGE WRITTEN AS 12 ON CONSENT BY PERSON IDENTIFYING AS FATHER. CHILD IDENTIFIED IN IMMTRAC (#148965307) WITH DATE OF BIRTH AS 7/13/2009. CHILD IS TOO YOUNG TO RECEIVE VACCINE IN JUNE 2021.  SEE VAERS #686977 FOR FIRST DOSE ON 5/15/2021.
Patient was waiting for about ten minutes after receiving vaccine when daughter alerted pharmacist that patient was unresponsive. Patient was emitting a choking, sputtering noise. Her hands were clenched so hard that pharmacist had difficulty separating them. Her head was extended backward and clenched. Patient's eyes were unfocused and rolled back. Pharmacist observed patient for about 15-30 seconds before administering epinephrine 0.3mg IM. Patient became responsive and was allowed to drink enough water to wet her mouth. Patient then vomited. EMS showed up within 5 minutes of incident and declared patient appeared normal other than an elevated heart rate. Patient declined further care from EMS. Pharmacist called patient after an hour to verify she was still fine, which she was.
Patient experienced 2 weeks of lethargy and malaise subsequent to PNEUMOVAX.  Back to normal state of health since.
pt recvd vax & devel rash, hives & v; tx for an allergic rxn by MD; pt devel rash in eve w/ hives & vomited again;
injection site pain and swelling; injection site pain and swelling; headache; muscle pain near injection site; neck ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 09:45 (Lot number: ER8732) at the age of 45 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 23Mar2021, outcome "recovered" and all described as "injection site pain and swelling"; HEADACHE (non-serious) with onset 23Mar2021, outcome "recovered", described as "headache"; MYALGIA (non-serious) with onset 23Mar2021, outcome "recovered", described as "muscle pain near injection site"; NECK PAIN (non-serious) with onset 23Mar2021, outcome "recovered", described as "neck ache". Therapeutic measures were not taken as a result of vaccination site pain, vaccination site swelling, headache, myalgia, neck pain.  Additional information: The patient had no known allergies. The patient did not receive any other vaccines within 4 week prior vaccination. The patient had not been diagnosed with COVID-19 prior vaccination and had not been tested for COVID-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
a little tenderness on the injection site; diarrhea; nausea; This is a spontaneous report from a contactable consumer. This 68-year-old female consumer reported for herself that she received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9261) at single dose on 24Jan2021 at 13:00 for COVID-19 immunisation. Relevant history included thyroid removal on 11Sep2019, and tumor removed from her appendix on May2020. Relevant family medical history was none.  Concomitant Products included: Levothyroxinesince Sep2019 and Ongoing.  FIBO tests in 2020 that were positive for Hydrogen FIBO. The patient experienced no symptoms by then except for a little tenderness on the injection site. On 26Jan2021, she experienced a sudden onset of diarrhea and nausea at 15:00.  Treatment included Zofran.  The patient stated that she did get the Vsafe contact but not today (26Jan2021). Outcome of event nausea was not resolved, outcome of other events was unknown. No emergency room required, no physician office visit. No any other vaccinations within four weeks prior to the first administration date of the suspect vaccine.
disoriented, completely confused; sort of non-verbal; weak; tired; shivers; A spontaneous report  was received from consumer concerning a 73-year-old, female patient, who experienced  being weak/asthenia, disorientated,completely confused/confusional state, tired/fatigue, shivering/chills and was sort of non-verbal/speech disorder.  The patient's medical history was not  provided by the reporter. The relevant concomitant medication use were not reported.  On 10 Mar 2021, prior to the onset of the events, the patient received the second of two planned doses of mRNA-1273 (Lot number:unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 11 Mar 2021, patient felt weak and tired. On 13 Mar 2021 the patient was completely confused, disoriented, sort of non-verbal, and had shivers.  She was hospitalized that day and was diagnosed with a stroke.  On 15 MAR 2021, the doctors removed the diagnosis of stroke but were unsure of what it was.   The treatment for the events included acetaminophen, metoprolol, losartan and nexium.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, weak/asthenia, disorientated,completely confused/confusional state, tired/fatigue, shivering/chills and was sort of non-verbal/speech disorder were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received from a female nurse who was vaccinated with 2 doses of varicella virus vaccine live. Subsequently, the patient had a negative titer. The patient then received 2 more doses of varicella virus vaccine live and had a positive IgG 3 weeks after the second dose in the second series. Unspecified medical attention was sought. Additional information has been requested.
Patient was leaving the room, when she told her mom that she wasn't feeling well. Then mother noticed that she had stopped walking and "appeared as though she had fainted". Mom and MA caught her before falling to the floor.  She was taking to an exam room, where she had recovered.  She said that she felt a little nauseated. After 10 minutes, she was assessed again and stated that she felt better. She was then released to go home.
Tingling around lips, butterfly rash on face; 3 weeks later rash extending to backs of hands, dry blurry eyes, dizzy spells. Treated with Cetirizine daily with daily Zantac, equipped with Epi-pen in case of emergency.
I received the two doses of the Pfizer COVID-19 vaccine. I was given the second dose (2/3/21) three weeks after the first dose (1/13/21). Some time after receiving the first dose, I noticed a subtle but definite strange feeling all around my mouth and tongue, like a "film" over everything. I also noticed a loss of taste. I suffered from anosmia and dysgeusia many years ago, but through medical intervention, I gained back over 90% of smell and 80% of taste. Now I've noticed more loss of taste again, and I don't think it's coincidence that it's happened while getting vaccinated. I just hope that I regain taste (which is only 45-50% now maybe) as time goes by.
This spontaneous report as received from a nurse practitioner refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history or concurrent conditions were not provided. On an unknown date, the patients were vaccinated with improperly stored doses of PEDVAXHIB (dose and route were not provided) lot # K025004 and expiry date on 22-JUL-2017. No adverse effects were reported. This is one of two reports from the same source. Additional information has been requested.
vertigo, dizziness, kind of low blood pressure sensation now and then for about three weeks after; vertigo, dizziness, kind of low blood pressure sensation now and then for about three weeks after; vertigo, dizziness, kind of low blood pressure sensation now and then for about three weeks after; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events vertigo, dizziness, kind of low blood pressure sensation now and then for about three weeks after the first dose of the vaccine.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: not provided) in the left arm for prophylaxis of COVID-19 infection.   On an unknown date, the patient experienced the events- vertigo, dizziness, kind of low blood pressure sensation now and then for about three weeks after the first dose of the vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(vertigo, dizziness, kind of low blood pressure sensation now and then for about three weeks after the first dose of the vaccine was unknown.
2:50pm S/p vaccination, reports "tingling sensation" on bilateral hands w/no other associated symptoms or complaints Vitals assessed BP 140/85 P99 RR 19,  hands / palms assessed w/noted redness bilaterally on initial assessment During medical monitoring symptoms dissipate w/no further complaints; BP130/85 P92 RR18 Released to home w/instructions to f/up prn
I received my booster on Sunday 12/11/22 at 4:30 PM. During the night of 12/11 I had muscle aches throughout my body. I got up at 7:30 AM on 12/12/22. Muscles no longer ached. Went to the bathroom. When I attempted to stand up I was momentarily very dizzy, apparently blacked out (syncope), fell, and was brought back to consciousness by my husband calling me. EMT arrived and while trying to get me onto a stretcher I had another syncope. I was taken to the emergency room at hospital, where I received the tests indicated below.  When I fell I apparently whacked my head, resulting in 3 staples in my scalp and a black eye. I have had a fever varying from 99-101.4 since the shot.
pt states that she developed a 101 fever the night of the vax and has had it for 2 days.  She has body aches, chills, and nausea.  Pt woke up drenching with sweat.  She has a rash on her body and face with red splotches on jaw line and neck.  She has tingling and numbness on both lips and arms. Pt contacted PCP and was told to take Benadryl and to FU tomorrow.
Pt was administered an expired vaccine. Exp 5.02.2020. Pt had no adverse reactions. Tolerated injection well.
One week after injection, appearance of a mildly itchy red rash on arm near the injection site, approximately 2.5 inches.
Each time I received a COVID-19 I have experienced the same side effects that last for about a week afterwards, shortness of breath, loss of energy, cough - especially when prone position. In addition, there can be some muscle soreness. I am in a program through the HCF for individuals that experience long-COVID-19 symptoms but have never had COVID-19. I was given naltrexone to help treat the symptoms of long-COVID-19.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  The reporter stated that, their facility had not been able to download the digital data logger, they had been put on hold by the state at the moment. There had been no power outages that would have impacted the Moderna vaccine.   It was reported that, the facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter did not have any questions and wanted to report this to Moderna.  The reporter stated that no adverse reactions were reported by any patients.
Information has been received from a nurse concerning her 83 year old father who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). Two to three months ago the patient got shingles on his back. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. No further information is available.
3x2 area of induration surrounding inject site (lt thigh) w/erythema & tenderness; also fever (tmax 39); rxn appeared in 24 hrs, resolved in 72 hrs;
Tinnitus, ringing in both ears, began 2 weeks post 2nd shot and has not subsided. Patient woke up in the middle of the night with ringing in right ear. By morning, ringing was experienced in both left and right ears.
Headache, injection site pain and some facial swelling initially Followed by a 6 by 3 inch itching rash on February 13th which I still have along with swollen glands. .
I felt a tingling sensation in my left arm, where I received my vaccine. Then I became hot and disoriented. I lost my vision for a few seconds and only saw grey. Then my hearing became muffled and I couldn't stand. I needed assistance standing. The episode lasted for a minute or two but I was very frightened. My mother gave me a bottle of water and sat for a while in the store. Then I went home. I did not seek any medical attention because I felt ok after. But my reaction to the vaccine was really scary.
Hives upper body including arms, neck stomach. Fever in 100 range for 4 days.
The vaccine vial that was used was not properly thawed according to guidelines. The vial contained partially frozen vaccine at the time it was administered, even though the vaccine dose was easily drawn into the syringe for administration. The patient has reported no adverse effects from the vaccine as of 8:45 AM on 1/19/21.
30 seconds of left facial numbness that began 8 hours after vaccination, found to be in decompensated heart failure
2:00 am seizure, dizzy, weak, diarrhea, nausea, head pain, rapid heart beat. This got better. 3:30 am bad seizure with foaming at nose and mouth, convulsions, dizzy, unable to move, terrible head pain, nausea, rapid heart beat, extreme hot and cold spells; freezing from bones out. The seizure got bettter after about an hour, but the tremors did not stop until around 6:00 am.The morning of the shot, I ate a banana for breakfast.  Only thing I ate after the shot was late lunch was rice with tomatos in it, green beans, fried squash (all out of my garden).
24 hrs post vaccination-vomited, chills, fever, seen at ER. Had CBC and chest film was started on Augmentin by pulmologist. Pt has primary pulmonary hypertension.
Information has been received from a physician concerning an 84 year old female who on 23-MAR-2007 was vaccinated SC with one dose of Zostavax. On 04-APR-2007 the patient came back to physician's office with mild case of shingles on her lower back. It was reported that the patient was treated with Zovirax. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/14/2007. Additional information has been received from a physician assistant who reported that on 02-Apr-2007 developed red blistery lesions as clusters on left upper buttocks which subsequently crusted/scabbed and resolved. NO diagnostic laboratory tests were undertaken. At the time of report the patient recovered. The patient experienced no adverse events following prior vaccination. No further information is expected. 06/22/07 This is in follow-up to report(s) previously submitted on 5/14/2007. Information has been received from a physician concerning an 84 year old female with type II diabetes mellitus, hypertension, osteoporosis, peripheral vascular insufficiency with neuropathy, hypothyroidism, atrial fibrillation and history of chickenpox as a child who on 23-MAR-2007 at 10:00 AM was vaccinated SC on left upper arm with 0.5 ml dose of ZOSTAVAX (Oka/Merck) (Lot # 656609/0015U). The patient did not have any recent exposure to chickenpox and shingles. On 04-APR-2007 the patient came back to physician's office with mild case of shingles on her lower back. It was reported that the patient was treated with ZOVIRAX. A product quality complaint was not involved. Additional information has been received from physician assistant who reported that on 02-APR-2007 developed red blistery lesions as clusters on left upper buttocks which subsequently crusted/scabbed and resolved. No diagnostic laboratory tests were undertaken. At the time of report the patient was recovered. The rash occurred at the site of injection. On 02-APR-2007 the patient developed shingles and had body temperature of 98 degree Fahrenheit. Other systemic symptoms included weakness. The patient rated her pain a 3-4 on a scale of 0 to 10 with 10 being the highest. A direct fluorescent antibody test was not undertaken. No specimen for polymerase chain reaction test was collected. No further information is expected.
6 days later--low grade fever, body aches, 2 areas of streaking redness on the arm--one at injection site and one newer area about 2 inches away from the site along scar from prior joint replacement surgery. + Lymphadenopathy. I have given patient a prescription for prednisone, but am watching for cellulitis as well.
pt recv vax & 4NOV97 pt exp 21 lesions w/a few vesicles on ankles & extremities;
Local vaccine reaction to right thigh 13cm circular lesion, warm to the touch, slight edema, redness.  Complain of pain, not very tender upon assessment KEFLEX 250/5 8ml three times a day for 7 days, BENADRYL 125/5 2 teaspoons every 6-8 hours as needed.  Recheck if no improvement 1 day.
I was in seeing my PCP and some of my tests came back with some levels that were concerning after checking my prostate and he sent me to a specialist. They did an MRI, and I was diagnosed with prostate cancer. I have since began radiation and treatment for the prostate cancer. At this point other than side effects from the radiation I am going to be tested again in March and hopefully it will show that the cancer is gone, and the treatment was effective.
In addition to expected fatigue, muscle and joint pain, in the morning of 1/8/22 I developed a rapid heartbeat. My resting HR was between 110 and 120 bpm over the course of the day, then in the evening of 1/8/22, I developed hives over my whole torso, arms and face. They did not itch and were not painful but were quite extensive.
Extreme pain across lower back above buttocks thru the night/ could not stand straight up or walk very well. Slept in chair Monday night. By Tuesday could straighten up, and Tylenol helped pain. By Wednesday morning all symptoms were gone. Addend: right arm tender for a week only when touched.
This spontaneous report was received from a nurse referring to a 9 weeks old patient of an unknown gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 14-OCT-2016, the patient was vaccinated with improperly stored dose of ROTATEQ lot # M006112 expiration date of 16-NOV-2017, (volume/dose reported as 2 (units not provided)) for prophylaxis. The vaccine was exposed to temperature of 49 Fahrenheit for 30 minutes. No previous temperature excursion was reported. The patient was vaccinated with private funds. No adverse effects and no product quality complaint (PQC) were reported. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1610USA004378: US-009507513-1610USA004376: US-009507513-1610USA004377: US-009507513-1610USA003097: US-009507513-1612USA006674: US-009507513-1612USA006673: US-009507513-1612USA006676: US-009507513-1612USA006672.
Day after pt received 2mo vax, pt with T101, given Tylenol which was vomited. Parents noted pt with seizure like activity; stiffening of arms, eye deviation, arching of back. Brought to ED with 2 more episodes in ED. Treated with IV Keppra. Discharged after neg CT.
Patient received her flu vaccination at a clinic.  Patient later contacted store concerned that the vaccine had been administered too low on her arm.  No adverse effects to patient health were reported.
I got the shot around 3:30 pm and around 3am the next morning I  woke up and my right thigh became numb, stayed numb for about 20 minutes.
Sore arm; Dryness on tip of tongue; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient experienced Sore arm and dryness on tip of tongue, both on 2021. The outcome was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On June 6, 2022 I became very achy. I took a COVID- 19 that wasn't positive June 8, 2022. It went into my sinuses where it has remained for weeks. I had a terrible taste in mouth that has gotten better but is still hanging. Because the sinus symptoms continued I went to an urgent care and was given an antibiotic for 7 days. It did absolutely nothing. I think whatever was going on my sinuses was viral and not bacterial.
GAVE PFIZER COVID 19 BIVALENT INSTEAD OF MONOVALENT FOR 2ND DOSE.  LEFT MSG FOR PT THAT PT RECEIVED BIVALENT BEFORE THE CDC APPROVAL DATE WHICH IS THE END OF THE MONTH.